Worldwide Cell Therapy Industry to 2027 - Increasing Prevalence of Chronic Diseases is Driving the Market

DUBLIN, April 1, 2021 /PRNewswire/ -- The "Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Therapy Type; Product; Technology; Application; End User, and Geography" report has been added to ResearchAndMarkets.com's offering.

According to this report the global cell therapy market is expected to reach US$ 12,563.23 million by 2027 from US$ 7,260.50 million in 2019. It is estimated to grow at a CAGR of 7.2% from 2020-2027. The growth of the market is attributed to increasing prevalence of chronic diseases, rising adoption of regenerative medicines, and surging number of approvals for cell-based therapies. However, the high cost of cell therapy manufacturing hinders the growth of the market.

The cell therapy market, based on therapy type, is bifurcated into allogeneic and autologous. In 2019, the allogeneic segment accounted for a larger share owing to the availability of substantial number of approved products for clinical use. For instance, in 2018, Alofisel developed by TiGenix (Takeda) is the first allogeneic stem cell-based therapy approved for use in Europe.

Chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, are the leading causes of death and disability worldwide. As per the Centers for Disease Control and Prevention (CDC), in 2019, nearly 6 in 10 people suffered from at least one chronic disease in the US. Cardiovascular diseases (CVDs) are a significant cause of mortality owing to the hectic lifestyle. As per the World Health Organization (WHO), CVDs are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. Cancer is among the leading causes of mortality worldwide, and the disease affects a huge population; therefore, it acts as a huge financial burden on society. According to the WHO, in 2018, ~9.6 million deaths occurred due to cancer globally. However, growing research on developing effective treatments for the disease is positively affecting the market growth. Gene therapy and cell therapy are transforming the cancer treatment landscape; for example, Novartis Kymriah is used to treat diffuse large B-cell lymphoma. The launches of more such products would be driving the demand for cell therapy, thus driving the growth of the cell therapy market in the coming years.

The COVID-19 outbreak was first reported in Wuhan (China) in December 2019. The pandemic is causing massive disruptions in supply chains, consumer markets, and economy across the world. As the healthcare sector is focusing on saving lives of COVID-19 patients, the demand for cell therapy is reducing worldwide.

Vericel Corporation; MEDIPOST; NuVasive, Inc.; Mesoblast Limited; JCR Pharmaceuticals Co. Ltd.; Smith & Nephew; Bristol-Myers Squibb Company; Cells for Cells; Stemedica Cell Technologies, Inc; and Castle Creek Biosciences, Inc. are among the companies operating in the cell therapy market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cell therapy market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global cell therapy market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cell Therapy Market - By Therapy Type
1.3.2 Global Cell Therapy Market - By Product
1.3.3 Global Cell Therapy Market - By Technology
1.3.4 Global Cell Therapy Market - By Application
1.3.5 Global Cell Therapy Market - By End User
1.3.6 Global Cell Therapy Market - By Geography

2. Cell Therapy Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Cell therapy- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East and Africa - PEST Analysis
4.2.5 South and Central America - PEST Analysis
4.3 Expert Opinions

5. Global Cell Therapy Market - Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in Developing Regions
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints

6. Cell therapy Market - Global Analysis
6.1 Global Cell therapy Market Revenue Forecast And Analysis
6.2 Global Cell therapy Market, By Geography - Forecast And Analysis
6.3 Market Positioning

7. Cell therapy Market Analysis - By Therapy Type
7.1 Overview
7.2 Cell therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.2 Allogeneic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Autologous
7.4.1 Overview
7.4.2 Autologous: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

8. Cell therapy Market Analysis - By Product
8.1 Overview
8.2 Cell therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.2 Consumables: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Equipment
8.4.1 Overview
8.4.2 Equipment: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Systems and Software
8.5.1 Overview
8.5.2 Systems and Software: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

9. Cell therapy Market Analysis - By Technology
9.1 Overview
9.2 Cell therapy Market Revenue Share, by Technology (2019 and 2027)
9.3 Viral Vector Technology
9.3.1 Overview
9.3.2 Viral Vector Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.2 Genome Editing Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.2 Somatic Cell Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

10. Cell therapy Market Analysis - By Application
10.1 Overview
10.2 Cell therapy Market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

11. Cell therapy Market Analysis - By End User
11.1 Overview
11.2 Cell therapy Market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Cell therapy Market - Revenue and Forecast to 2027 (US$ Million)

12. Cell therapy Market - Geographic Analysis
12.1 North America: Cell Therapy Market
12.2 Europe: Cell therapy Market
12.3 Asia Pacific: Cell Therapy Market
12.4 Middle East and Africa: Cell Therapy Market
12.5 South and Central America: Cell Therapy Market

13. Impact of COVID-19 Pandemic on Global Cell Therapy Market
13.1 North America: Impact Assessment of COVID-19 Pandemic
13.2 Europe: Impact Assessment of COVID-19 Pandemic
13.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
13.5 South & Central America: Impact Assessment of COVID-19 Pandemic

14. Cell Therapy Market- Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Organic Developments
14.3.1 Overview
14.4 Inorganic Developments
14.4.1 Overview

15. Company Profiles
15.1 Vericel Corporation
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 MEDIPOST
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 NuVasive, Inc.
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 Mesoblast Limited
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 JCR Pharmaceuticals Co. Ltd.
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Smith & Nephew
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Bristol-Myers Squibb Company
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
15.8 Cells for Cells
15.8.1 Key Facts
15.8.2 Business Description
15.8.3 Products and Services
15.8.4 Financial Overview
15.8.5 SWOT Analysis
15.8.6 Key Developments
15.9 Stemedica Cell Technologies, Inc
15.9.1 Key Facts
15.9.2 Business Description
15.9.3 Products and Services
15.9.4 Financial Overview
15.9.5 SWOT Analysis
15.9.6 Key Developments
15.10 Castle Creek Biosciences, Inc.
15.10.1 Key Facts
15.10.2 Business Description
15.10.3 Products and Services
15.10.4 Financial Overview
15.10.5 SWOT Analysis
15.10.6 Key Developments

16. Appendix
16.1 About the Publisher
16.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/hxk6k0

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets